 Bifeng Gao
Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| NF-E2-Related Factor 2 | 3 | 2021 | 95 | 0.870 |
Why?
| | Pulmonary Alveoli | 4 | 2024 | 383 | 0.280 |
Why?
| | Cachexia | 1 | 2025 | 75 | 0.210 |
Why?
| | Alveolar Epithelial Cells | 1 | 2024 | 120 | 0.200 |
Why?
| | Regeneration | 1 | 2024 | 197 | 0.190 |
Why?
| | Pulmonary Emphysema | 1 | 2024 | 275 | 0.180 |
Why?
| | Oxidative Stress | 3 | 2019 | 1339 | 0.180 |
Why?
| | Superoxide Dismutase | 1 | 2003 | 301 | 0.170 |
Why?
| | Head and Neck Neoplasms | 1 | 2025 | 558 | 0.160 |
Why?
| | Recombinant Fusion Proteins | 1 | 2003 | 675 | 0.160 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 25 | 0.150 |
Why?
| | Antioxidants | 3 | 2019 | 549 | 0.140 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 920 | 0.130 |
Why?
| | Genetic Background | 1 | 2016 | 16 | 0.120 |
Why?
| | Pneumonia | 1 | 2003 | 631 | 0.120 |
Why?
| | Myoblasts | 1 | 2017 | 84 | 0.120 |
Why?
| | Immunity, Innate | 3 | 2012 | 846 | 0.120 |
Why?
| | Gene Rearrangement | 1 | 2016 | 155 | 0.120 |
Why?
| | Cell Division | 1 | 2017 | 766 | 0.110 |
Why?
| | Epithelial Cells | 2 | 2014 | 1125 | 0.110 |
Why?
| | Lung Neoplasms | 4 | 2013 | 2637 | 0.110 |
Why?
| | Hypoxia | 1 | 2022 | 1199 | 0.110 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2014 | 69 | 0.100 |
Why?
| | Genome | 1 | 2016 | 306 | 0.100 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2010 | 1455 | 0.100 |
Why?
| | Chromosomal Instability | 1 | 2013 | 21 | 0.100 |
Why?
| | Microarray Analysis | 1 | 2013 | 117 | 0.100 |
Why?
| | Cell Hypoxia | 1 | 2014 | 247 | 0.100 |
Why?
| | Glycoproteins | 1 | 2014 | 355 | 0.090 |
Why?
| | Precancerous Conditions | 1 | 2013 | 166 | 0.090 |
Why?
| | Muscle, Skeletal | 2 | 2025 | 1795 | 0.090 |
Why?
| | Genomics | 1 | 2016 | 834 | 0.080 |
Why?
| | Fetal Growth Retardation | 1 | 2017 | 587 | 0.080 |
Why?
| | Hypertension, Pulmonary | 1 | 2022 | 1980 | 0.080 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2012 | 157 | 0.080 |
Why?
| | Influenza A virus | 1 | 2011 | 113 | 0.080 |
Why?
| | Macrophages | 2 | 2022 | 1511 | 0.080 |
Why?
| | Animals | 11 | 2025 | 38058 | 0.070 |
Why?
| | Disease Models, Animal | 3 | 2025 | 4557 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2017 | 2496 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 983 | 0.070 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2013 | 641 | 0.070 |
Why?
| | Cluster Analysis | 3 | 2022 | 521 | 0.070 |
Why?
| | Down-Regulation | 1 | 2010 | 627 | 0.070 |
Why?
| | Smoke | 1 | 2009 | 148 | 0.070 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2007 | 34 | 0.070 |
Why?
| | Models, Animal | 1 | 2009 | 392 | 0.070 |
Why?
| | Diet, Reducing | 1 | 2007 | 91 | 0.070 |
Why?
| | Breast | 1 | 2007 | 158 | 0.060 |
Why?
| | Blood Platelets | 1 | 2010 | 400 | 0.060 |
Why?
| | Genome-Wide Association Study | 1 | 2013 | 1406 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 3 | 2014 | 2527 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2014 | 2608 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2145 | 0.060 |
Why?
| | Influenza, Human | 1 | 2012 | 616 | 0.060 |
Why?
| | Mice | 5 | 2025 | 18339 | 0.060 |
Why?
| | Caenorhabditis elegans | 1 | 2009 | 337 | 0.060 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2025 | 15 | 0.060 |
Why?
| | Tripartite Motif Proteins | 1 | 2025 | 40 | 0.060 |
Why?
| | Gene Expression Profiling | 2 | 2010 | 1782 | 0.060 |
Why?
| | Herpesvirus 3, Human | 1 | 2009 | 336 | 0.060 |
Why?
| | Rats | 4 | 2014 | 5597 | 0.060 |
Why?
| | Uteroglobin | 1 | 2024 | 30 | 0.050 |
Why?
| | RNA, Viral | 1 | 2009 | 688 | 0.050 |
Why?
| | Cell Line | 3 | 2019 | 2882 | 0.050 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 1180 | 0.050 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2024 | 45 | 0.050 |
Why?
| | Muscular Atrophy | 1 | 2025 | 89 | 0.050 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2025 | 214 | 0.050 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2025 | 192 | 0.050 |
Why?
| | HIV Infections | 1 | 2019 | 3154 | 0.050 |
Why?
| | Muscle Proteins | 1 | 2025 | 244 | 0.050 |
Why?
| | Carrageenan | 1 | 2003 | 8 | 0.050 |
Why?
| | Organoids | 1 | 2024 | 141 | 0.050 |
Why?
| | Aged | 2 | 2021 | 25913 | 0.050 |
Why?
| | Humans | 12 | 2024 | 144759 | 0.050 |
Why?
| | Edema | 1 | 2003 | 124 | 0.050 |
Why?
| | Extremities | 1 | 2003 | 140 | 0.040 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2002 | 66 | 0.040 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2003 | 269 | 0.040 |
Why?
| | Testis | 1 | 2002 | 163 | 0.040 |
Why?
| | Plasmids | 1 | 2003 | 379 | 0.040 |
Why?
| | Heparin | 1 | 2003 | 244 | 0.040 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2002 | 162 | 0.040 |
Why?
| | Antigens, Neoplasm | 1 | 2002 | 271 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2009 | 2832 | 0.040 |
Why?
| | Chemokines | 2 | 2012 | 218 | 0.040 |
Why?
| | Stem Cells | 1 | 2024 | 626 | 0.040 |
Why?
| | Antioxidant Response Elements | 1 | 2019 | 5 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2022 | 442 | 0.040 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2019 | 10 | 0.040 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2019 | 34 | 0.040 |
Why?
| | Base Sequence | 1 | 2003 | 2190 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 851 | 0.040 |
Why?
| | Heme Oxygenase-1 | 1 | 2019 | 74 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2003 | 961 | 0.040 |
Why?
| | Molecular Sequence Data | 1 | 2003 | 2930 | 0.030 |
Why?
| | HIV | 1 | 2019 | 250 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3540 | 0.030 |
Why?
| | Male | 6 | 2025 | 72315 | 0.030 |
Why?
| | Neutrophils | 1 | 2003 | 1134 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2019 | 635 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2019 | 621 | 0.030 |
Why?
| | Translocation, Genetic | 1 | 2016 | 115 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2012 | 758 | 0.030 |
Why?
| | Mice, Transgenic | 2 | 2016 | 2182 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2019 | 1087 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2002 | 1313 | 0.030 |
Why?
| | Lymphoma | 1 | 2016 | 232 | 0.030 |
Why?
| | Female | 6 | 2025 | 78271 | 0.030 |
Why?
| | Mice, Inbred C57BL | 1 | 2025 | 5992 | 0.030 |
Why?
| | Sheep | 1 | 2017 | 880 | 0.030 |
Why?
| | Loss of Heterozygosity | 1 | 2013 | 52 | 0.030 |
Why?
| | Fetal Development | 1 | 2017 | 299 | 0.020 |
Why?
| | Chromosome Aberrations | 1 | 2013 | 162 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2016 | 549 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2019 | 869 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 2027 | 0.020 |
Why?
| | Middle Aged | 4 | 2024 | 35875 | 0.020 |
Why?
| | Lectins, C-Type | 1 | 2012 | 62 | 0.020 |
Why?
| | Drugs, Chinese Herbal | 1 | 2011 | 24 | 0.020 |
Why?
| | Computational Biology | 1 | 2016 | 680 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 851 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 341 | 0.020 |
Why?
| | B-Lymphocytes | 1 | 2016 | 876 | 0.020 |
Why?
| | Genes, Neoplasm | 1 | 2010 | 25 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2010 | 105 | 0.020 |
Why?
| | Surface-Active Agents | 1 | 2011 | 92 | 0.020 |
Why?
| | Phagocytosis | 1 | 2012 | 299 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2010 | 197 | 0.020 |
Why?
| | Demography | 1 | 2010 | 288 | 0.020 |
Why?
| | Exons | 1 | 2010 | 358 | 0.020 |
Why?
| | Cotinine | 1 | 2009 | 79 | 0.020 |
Why?
| | Electrophoresis, Capillary | 1 | 2009 | 19 | 0.020 |
Why?
| | RNA Splicing | 1 | 2010 | 284 | 0.020 |
Why?
| | Lung | 1 | 2022 | 4109 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2011 | 380 | 0.020 |
Why?
| | Kinetics | 1 | 2012 | 1627 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3409 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2009 | 168 | 0.020 |
Why?
| | Methylnitrosourea | 1 | 2007 | 7 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 688 | 0.020 |
Why?
| | DNA Primers | 1 | 2009 | 512 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 476 | 0.020 |
Why?
| | Carcinogens | 1 | 2007 | 122 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 4154 | 0.020 |
Why?
| | Pseudomonas aeruginosa | 1 | 2009 | 356 | 0.020 |
Why?
| | Nicotine | 1 | 2009 | 331 | 0.020 |
Why?
| | Insulin | 1 | 2017 | 2507 | 0.010 |
Why?
| | Cytokines | 1 | 2012 | 2061 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1985 | 0.010 |
Why?
| | Pregnancy | 1 | 2017 | 7190 | 0.010 |
Why?
| | Smoking | 1 | 2011 | 1472 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2011 | 2050 | 0.010 |
Why?
| | Methylcholanthrene | 1 | 2002 | 21 | 0.010 |
Why?
| | Butylated Hydroxytoluene | 1 | 2002 | 36 | 0.010 |
Why?
| | Multigene Family | 1 | 2002 | 204 | 0.010 |
Why?
| | Dinoprostone | 1 | 2002 | 178 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2002 | 919 | 0.010 |
Why?
| | Inflammation | 1 | 2011 | 2878 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2002 | 636 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2011 | 8265 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2002 | 1716 | 0.010 |
Why?
| | Signal Transduction | 1 | 2011 | 5226 | 0.010 |
Why?
| | Adult | 1 | 2011 | 40449 | 0.000 |
Why?
|
|
Gao's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|